• by bcarlson@marketresearch.com
  • December 16 2013

Infectious Diseases Exact Staggering Toll

Infectious Diseases Exact Staggering Toll

As noted in our Infectious Disease Diagnostic Test Market  report, infectious diseases take a toll on the world economy, which is why IVD products are needed to help diagnose them faster.  For example, WHO’s Roll Back Malaria estimates that infectious diseases result in a direct cost of some $12 billion or 1.3% of GDP growth per year for Africa.  For Nigeria alone the direct loss to the economy is estimated at $850 million.  (www.rbm.who.int)  The cost of malaria is approximately 40% of public health spending in sub-Saharan Africa and it accounts for 20-50% of inpatient admissions and up to 50% of outpatient visits.

An analysis by the Pan American Health Organization (PAHO), indicates that neglected tropical diseases (NTDs) as a group may have surpassed HIV/AIDS, tuberculosis and malaria as the most prevalent infectious diseases in Latin America and the Caribbean.

The analysis found that NTDs are the most common infections of approximately 200 million of the poorest people in the region. They include tens of millions of cases of intestinal worm infections, and almost 10 million cases of Chagas disease, as well as schistosomiasis, trachoma, dengue fever, leishmaniasis, lymphatic filariasis (LF), and onchocerciasis.

These factors, and the efforts by WHO, the Gates Foundation and others to prevent infectious disease, will make IDIVD a much-needed area for the next 5-10 years, according to Kalorama’s market analysis.